Discover
ACXP
Acurx Pharmaceuticals, Inc.
1.27
2 x 0.91
2 x 1.63
bid
ask
+
0.02
1.60%
2 @ 04:00 PM
1.25 -0.02 (1.57%)
| Ytd | -49.00% | |
| 1y | -82.93% |
1.24
day range
1.28
1.25
52 week range
7.59
| Open | 1.24 | Prev Close | 1.25 | Low | 1.24 | High | 1.28 | Mkt Cap | 7.06M |
| Vol | 41.15K | Avg Vol | 125.08K | EPS | -2.73 | P/E | N/A | Forward P/E | -0.56 |
| Beta | -1.72 | Short Ratio | 12.59 | Inst. Own | 11.96% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-11 | 50-d Avg | 1.40 | 200-d Avg | 2.12 | 1yr Est | 11.19 |
| Income Statement | |||
| Operating Expenses | 2.31M | ||
| Research and Development Expense | 1.07M | ||
| Selling, General and Administrative Expense | 1.24M | ||
| Operating Income | -2.31M | ||
| Net Income | -2.25M | ||
| Net Income Common Stock | -2.25M | ||
| Net Income Common Stock (USD) | -2.25M | ||
| Consolidated Income | -2.25M | ||
| Earnings per Basic Share | -0.53 | ||
| Earnings per Basic Share (USD) | -0.53 | ||
| Earnings per Diluted Share | -0.53 | ||
| Earning Before Interest & Taxes (EBIT) | -2.25M | ||
| Earning Before Interest & Taxes (USD) | -2.25M | ||
| Weighted Average Shares | 4.26M | ||
| Weighted Average Shares Diluted | 4.26M | ||
| Balance Sheet | |||
| Cash and Equivalents | 10.66M | ||
| Cash and Equivalents (USD) | 10.66M | ||
| Trade and Non-Trade Receivables | 95.31K | ||
| Current Assets | 10.98M | ||
| Total Assets | 10.98M | ||
| Current Liabilities | 2.83M | ||
| Total Liabilities | 2.83M | ||
| Accumulated Retained Earnings (Deficit) | -79.22M | ||
| Shareholders Equity | 8.15M | ||
| Shareholders Equity (USD) | 8.15M | ||
| Trade and Non-Trade Payables | 2.83M | ||
| Cash Flow | |||
| Net Cash Flow from Financing | 3.11M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 1.40M | ||
| Issuance (Purchase) of Equity Shares | 3.11M | ||
| Net Cash Flow from Operations | -1.71M | ||
| Share Based Compensation | 200.54K | ||